Bell Therapeutics is developing a second-generation digital therapeutics
that activates specific parts of the patient's brain through software.
Unlike first-generation digital therapeutics, which generally require
a treatment period of 4 to 9 weeks or more, second-generation
digital therapeutics introduce a new concept that implements
the mechanism of drugs through software, exhibiting immediate efficacy
within 30 to 60 minutes. Through our proprietary sonification technology,
we present a new concept of digital therapeutics that stimulate
the brain without side effects.